Inify Laboratories – now listed on Euronext Growth in Oslo under the INIFY ticker
Stockholm, June 20[th] 2022“Today I’m truly thrilled to announce that Inify Laboratories is admitted to trading on Euronext Growth Oslo, less than 5 months after we became independent. With solid funding of NOK 150 million, provided through an equity issue towards supportive long-term shareholders as well as the management and Board of Directors, we have all prerequisites in place to develop the company and create a monumental paradigm shift within cancer diagnostics,” says Inify Laboratory’s CEO Fredrik Palm. Inify Laboratories is currently building and establishing an ultra-modern